These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38873193)

  • 1. Case report: Autoimmune encephalomyelitis following cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
    Yang M; Cai Y; Wan L; Ji L; Song XM
    Front Med (Lausanne); 2024; 11():1373062. PubMed ID: 38873193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical study of lyophilized intravenous human immunoglobulin containing high-titer cytomegalovirus-neutralizing antibody for the treatment of cytomegalovirus viremia after allogeneic hematopoietic stem cell transplantation.
    Zhang P; Yang D; Tian J; Feng S; Jiang E; Han M
    Ann Palliat Med; 2021 May; 10(5):5533-5540. PubMed ID: 34107701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor CMV-specific cytotoxic T lymphocytes successfully treated drug-resistant cytomegalovirus encephalitis after allogeneic hematopoietic stem cell transplantation.
    Ke P; Bao X; Zhou J; Li X; Zhuang J; He X; Wu D; Zhang X; Ma X
    Hematology; 2020 Dec; 25(1):43-47. PubMed ID: 31906810
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytomegalovirus management after allogeneic hematopoietic stem cell transplantation: A mini-review.
    Jerry Teng CL; Wang PN; Chen YC; Ko BS
    J Microbiol Immunol Infect; 2021 Jun; 54(3):341-348. PubMed ID: 33514495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case of Multiple Sclerosis-Like Relapsing Remitting Encephalomyelitis Following Allogeneic Hematopoietic Stem Cell Transplantation and a Review of the Published Literature.
    Das J; Gill A; Lo C; Chan-Lam N; Price S; Wharton SB; Jessop H; Sharrack B; Snowden JA
    Front Immunol; 2020; 11():668. PubMed ID: 32431694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic letermovir decreases cytomegalovirus reactivation after stem cell transplantation: a single-center real-world evidence study.
    Serio B; Giudice V; Guariglia R; Fontana R; Pezzullo L; Martorelli MC; Ferrara I; Mettivier L; D'Addona M; Vaccaro E; Langella M; Selleri C
    Infez Med; 2021 Mar; 29(1):102-113. PubMed ID: 33664179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation of the utility of plasma Cytomegalovirus (CMV) microRNA detection to predict CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.
    Talaya A; Giménez E; Pascual MJ; Gago B; Piñana JL; Hernández-Boluda JC; Vázquez L; García M; Serrano D; Hernández M; Albert E; Solano C; Navarro D
    Med Microbiol Immunol; 2020 Feb; 209(1):15-21. PubMed ID: 31478067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of inflammatory biomarkers in plasma predict the occurrence and features of cytomegalovirus DNAemia episodes in allogeneic hematopoietic stem cell transplant recipients.
    Talaya A; Giménez E; Vinuesa V; Pérez A; Amat P; Piñana JL; Albert E; Hernández-Boluda JC; Solano C; Navarro D
    Med Microbiol Immunol; 2019 Aug; 208(3-4):405-414. PubMed ID: 30911925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of human herpesvirus-6 in allogeneic hematopoietic stem cell transplant recipients in correlation with cytomegalovirus infection].
    Wang LR; Dong LJ; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1204-9. PubMed ID: 17204195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality.
    Liu J; Kong J; Chang YJ; Chen H; Chen YH; Han W; Wang Y; Yan CH; Wang JZ; Wang FR; Chen Y; Zhang XH; Xu LP; Liu KY; Huang XJ
    Clin Microbiol Infect; 2015 Dec; 21(12):1121.e9-15. PubMed ID: 26093077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing the treatment of cytomegalovirus infection in allo-HSCT recipients.
    Sun YQ; Ma R; Huang XJ
    Expert Rev Clin Immunol; 2023 Feb; 19(2):227-235. PubMed ID: 36541485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of CMV-IVIg as prophylaxis against cytomegalovirus reactivation in allogeneic hematopoietic stem cell transplantation patients.
    Cui J; Zhou Y; Zhao K; Li X; Zhang H; Zhang X; Sun Y; Long B
    Clin Transplant; 2024 Apr; 38(4):e15300. PubMed ID: 38555576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Features of cytomegalovirus infection and evaluation of cytomegalovirus-specific T cells therapy in children's patients following allogeneic hematopoietic stem cell transplantation: A retrospective single-center study.
    Ruan Y; Luo T; Liu Q; Liu X; Chen L; Wen J; Xiao Y; Xie D; He Y; Wu X; Feng X
    Front Cell Infect Microbiol; 2022; 12():1027341. PubMed ID: 36339340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mutations in the
    Demin MV; Tikhomirov DS; Biderman BV; Drokov MY; Sudarikov AB; Tupoleva TA; Filatov FP
    Vopr Virusol; 2022 Mar; 67(1):37-47. PubMed ID: 35293187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The time-dependent effects of early-onset Epstein-Barr viremia on adult acute leukemia patients following allo-HSCT with ATG-containing MAC regimen.
    Ke P; Zhang X; Liu S; Zhu Q; Ma X; Chen F; Tang X; Han Y; Fu Z; Chen S; Wu D; Qiu H; Zhou J; Bao X
    Ann Hematol; 2021 Jul; 100(7):1879-1889. PubMed ID: 33885923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of low cytomegalovirus viral load thresholds for preemptive antiviral therapy in hematopoietic cell transplant recipients].
    Li L; Wang Y; Yan CH; Huang XJ
    Zhonghua Nei Ke Za Zhi; 2018 Mar; 57(3):191-195. PubMed ID: 29518863
    [No Abstract]   [Full Text] [Related]  

  • 18. Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT.
    Neuenhahn M; Albrecht J; Odendahl M; Schlott F; Dössinger G; Schiemann M; Lakshmipathi S; Martin K; Bunjes D; Harsdorf S; Weissinger EM; Menzel H; Verbeek M; Uharek L; Kröger N; Wagner E; Kobbe G; Schroeder T; Schmitt M; Held G; Herr W; Germeroth L; Bonig H; Tonn T; Einsele H; Busch DH; Grigoleit GU
    Leukemia; 2017 Oct; 31(10):2161-2171. PubMed ID: 28090089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of Cytomegalovirus Antigenemia Guides Prophylaxis of Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation].
    Fan W; Li YH; Dong LJ; Pian HY; Lu SJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2001 Jun; 9(2):149-152. PubMed ID: 12578623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus infection and rehospitalization rates after allogeneic hematopoietic stem cell and solid organ transplantation: a retrospective cohort study using German claims data.
    Teschner D; Knop J; Piehl C; Junker S; Witzke O
    Infection; 2022 Dec; 50(6):1543-1555. PubMed ID: 35633464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.